Compound as ctps1 inhibitor
AssigneesHangzhou Innogate Pharma Co., Ltd., Innorace Biopharma Co., Ltd.
InventorsHancheng ZHANG, Congcong CAI, Shiya ZHU
Life of this patent
Estimating the term…
Abstract
Provided in the present invention is a class of compounds. Specifically, provided in the present invention is a compound having a struc-ture as shown in formula (1), or an optical isomer, pharmaceutically accept-able salt, prodrug, deuterated derivative, hydrate and solvate thereof. The compound can effectively inhibit CTPS 1, and is used for treating or prevent-ing diseases or disorders associated with the activity or expression quantity of CTPS1.
Claims17
A compound of formula (I), or an optical isomer, pharmaceutically acceptable salt, prodrug, deuterated derivative, hydrate, or solvate thereof:
- wherein in formula (I):
- A is selected from Formula (Ia), Formula (Ib), or Formula (Ic):
- wherein in Formula (Ia), Formula (Ib), and Formula (Ic), “” represents the point which attach to Ar1 in the compound of Formula (I);
- “” represents the point which attach to B in the compound of Formula (I);
- B is —NHC(═O)— or —C(═O)NH—;
- Ar1, Ar2 and Ar3 are each independently selected from aryl and heteroaryl;
- R is selected from C1-6 alkyl, C3-6 cycloalkyl, 3- to 6-membered heterocyclyl, C3-6 cycloalkyl-C1-4 alkyl, 3- to 6-membered heterocyclyl-C1-4 alkyl, C3-6 cycloalkyl-C2-4alkynyl, 3- to 6-membered heterocyclyl-C2-4alkynyl, and C3-6 cycloalkyl-C(═O)—C1-2 alkyl;
- R1 is selected from hydrogen, halogen, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy and CN;
- R2 is selected from hydrogen, halogen, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy, C1-4 haloalkoxy, and CN;
- R3 is selected from hydrogen, halogen, C1-4 alkyl, C1-4 haloalkyl, C2-4 alkenyl, C2-4 alkynyl, C3-6 cycloalkyl, C3-6 cycloalkyl-C1-4 alkyl, C3-6 cycloalkyl-C2-4alkynyl, 3- to 6-membered heterocyclyl, 3- to 6-membered heterocyclyl-C2-4alkynyl, ORa, SRa, NRcRc, CN, or a group of Formula (Ie) (as shown below);
- wherein Ra is selected from hydrogen, C1-4 alkyl, C1-4 haloalkyl, C3-6 cycloalkyl, or C3-6 cycloalkyl-C1-4 alkyl;
- each Rc is independently selected from hydrogen, C1-4 alkyl, and C1-4 haloalkyl;
- R4 is selected from hydrogen, halogen, C1-4 alkyl, C1-4 haloalkyl, hydroxy, C1-4 alkoxy, and CN;
- R5 is selected from hydrogen, C1-4 alkyl, C3-6 cycloalkyl, 3- to 6-membered heterocyclyl, aryl, and heteroaryl;
- M is selected from CRhRi;
- wherein Rh and Ri are each independently selected from hydrogen, halogen, C1-4 alkyl, C3-6 cycloalkyl, 3- to 8-membered heterocyclyl, aryl, heteroaryl, CN, C(O)Rg, C(O)ORf, or C(O)NRdRd;
- wherein said alkyl, cycloalkyl, heterocyclyl, aryl, and heteroaryl are each optionally substituted by one or more substituents independently selected from the group consisting of:
- halogen, C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl, C3-6 cycloalkyl, 3- to 6-membered heterocyclyl, aryl, heteroaryl, CN, ORf, SRf, NRdRd, C(O)Rg, C(O)Of, OC(O)Rg, C(O)NRdRd, NRdC(O)Rg, NRdC(O)NRdRd, OC(O)NRdRd, NRdC(O)ORf, OC(O)ORf, S(O)2NRdRd, NRdS(O)2Rg, and NRdS(O)2NRdRd;
- or Rh and Ri together with the carbon atom to which they are attached form a 3- to 8-membered cyclic structure, said cyclic structure optionally containing 0, 1, or 2 heteroatoms independently selected from N, O and S, and optionally substituted by one or more substituents independently selected from the group consisting of halogen, C1-4 alkyl, CN, ORf, SRf, NRdRd, and =M, wherein M is as defined above;
- wherein each Rd is independently selected from hydrogen, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxyC2-4alkyl, C3-6 cycloalkyl, and 3- to 6-membered heterocyclyl;
- each Rf is independently selected from hydrogen, C1-4 alkyl, C1-4 haloalkyl, C3-6 cycloalkyl, and 3- to 6-membered heterocyclyl;
- each Rg is independently selected from hydrogen, C1-4 alkyl, C1-4 haloalkyl, C2-4 alkenyl, C2-4 alkynyl, C3-6 cycloalkyl, 3- to 6-membered heterocyclyl, aryl, and heteroaryl;
- X and Y are each independently selected from O, CReRe and NRb;
- wherein each Re is independently selected from hydrogen, halogen, C1-4 alkyl, C3-6 cycloalkyl, 3- to 6-membered heterocyclyl, aryl, heteroaryl, CN, ORf, SRf, NRdRd, C(O)Rg, C(O)ORf, OC(O)Rg, C(O)NRdRd, NRdC(O)Rg, NRdC(O)NRdRd, OC(O)NRdRd, NRdC(O)ORf, OC(O)ORf, S(O)2NRdRd, NRdS(O)2Rg and NRdS(O)2NRdRd;
- Rb is selected from hydrogen, C1-4 alkyl, C3-6 cycloalkyl, 3- to 6-membered heterocyclyl, aryl, heteroaryl, C(O)Rg, C(O)ORf, C(O)NRdRd, S(O)2NRdRd and S(O)2Rg;
- the alkyl in Re or Rb is optionally substituted by one or more substituents selected from the group consisting of halogen, C3-6 cycloalkyl, 3- to 6-membered heterocyclyl, aryl, heteroaryl, CN, ORf, SRf, NRdRd, C(O)Rg, C(O)Of, OC(O)Rg, C(O)NRdRd, NRdC(O)Rg, NRdC(O)NRdRd, OC(O)NRdRd, NRdC(O)ORf, OC(O)ORf, S(O)2NRdRd, NRdS(O)2Rg, and NRdS(O)2NRdRd;
- Rd, Rf, Rg are defined as above;
- provided that when A is formula (Ic) and Y is NRb, then NRb is selected from aryl, heteroaryl, C(O)Rg′, or Formula (Id),
- wherein “” represents the point which attach to N in Formula (Id);
- Rg′ is selected from C2-4 alkenyl, C2-4 alkynyl, C3-6 cycloalkyl, or 3- to 6-membered heterocyclyl;
- M′ is selected from O or CRhRi;
- R4, Rh and Ri are as defined above;
- with the proviso that, when A is selected from formula (Ic), Y is selected from O, CReRe, or NRb, and Rb is other than aryl, heteroaryl, C(O)Rg′, and Formula (Id), then R is selected from C3-6 cycloalkyl-C2-4 alkynyl, 3- to 6-membered heterocyclyl C2-4 alkynyl, or C3-6 cycloalkyl C(═O)C1-2 alkyl;
- or R3 is selected from C3-6 cycloalkyl-C2-4 alkynyl, 3- to 6-membered heterocyclyl C2-4 alkynyl, or formula (Ie);
- wherein “” represents the point which attach to Ar3 in Formula (Ie);
- and Re, Rb, Rg′, M′, and R4 are as defined above;
- wherein p1, p2 and p3 are each independently selected from 0, 1, 2 and 3;
- each m and each n are independently selected from 0, 1, 2, 3, 4, 5 and 6;
- provided that m and n are not both 0;
- each q is independently selected from 0, 1, 2, 3 and 4;
- wherein each of the aforementioned alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, cyclic structure, aryl, and heteroaryl groups is optionally and independently substituted by 1 to 3 substituents independently selected from the group consisting of:
- halogen, C1-4 alkyl, C1-4 haloalkyl, C2-4 alkenyl, C2-4 alkynyl, C3-8 cycloalkyl, 3- to 8-membered heterocyclyl, aryl, heteroaryl, CN, NO2, ORf, SRf, NRdRd, C(O)Rg, C(O)ORf, C(O)NRdRd, NRdC(O)Rg, NRdS(O)2Rg and S(O)2Rg, provided that the resulting chemical structure is stable and chemically meaningful;
- wherein Rd, Rf, and Rg are as defined above;
- unless otherwise specified, the aforementioned aryl is an aromatic group containing 6 to 12 carbon atoms;
- heteroaryl is a 5- to 15-membered heteroaromatic group;
- and cyclic structure is a saturated or unsaturated cyclic group which optionally containing heteroatoms.
Dependencies are inferred from the claim text.